发明名称 KAPPA/LAMBDA CHIMERIC ANTIGEN RECEPTORS
摘要 The invention provides improved vector composition comprising chimeric antigen receptor for adoptive T cell therapies.
申请公布号 US2017049819(A1) 申请公布日期 2017.02.23
申请号 US201515306721 申请日期 2015.04.24
申请人 bluebird bio, Inc. 发明人 Friedman Kevin;Ryu Byoung
分类号 A61K35/17;C12N5/0783;C07K16/28;C07K14/725;C07K14/705 主分类号 A61K35/17
代理机构 代理人
主权项 1. A chimeric antigen receptor (CAR) comprising: a) an extracellular domain that binds one or more epitopes of a human kappa light chain polypeptide; b) a transmembrane domain derived from a polypeptide selected from the group consisting of: CD8a; CD4, CD45, PD1, and CD152; c) one or more intracellular co-stimulatory signaling domains selected from the group consisting of: CD28, CD54 (ICAM), CD134 (OX40), CD137 (41BB), CD152 (CTLA4), CD273 (PD-L2), CD274 (PD-L1), and CD278 (ICOS); and d) a CD3ζ primary signaling domain.
地址 Cambridge MA US